Iressa/Docetaxel in Non-Small-Cell Lung Cancer

NCT00048087 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: ZD1839
DRUG: Docetaxel

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]